Latest Tocotrienol Stories
DELRAY BEACH, Fla., June 23, 2011 /PRNewswire/ -- As media coverage on radiation increases in the U.S., there's growing concern about the possible effects of excess exposure from different types of radiation. Not only is the U.S.
SINGAPORE, May 30, 2011 /PRNewswire-Asia/ -- Davos Life Science (DavosLife) has today announced preliminary results of a phase I clinical trial of its Natural e3 delta-tocotrienol (Natural e3) in patients with resectable pancreatic cancer.
SINGAPORE, March. 2, 2011 /PRNewswire-Asia/ -- Davos Life Science, the world's largest tocotrienols manufacturer and research company, today announced that it has been awarded the 2010 Asia Pacific Frost & Sullivan Excellence in Research Award in the Natural Vitamin E Market.
ST. LOUIS, Feb. 24, 2011 /PRNewswire/ -- ZeaVision adds EyePromise EZ Tears to its brand of doctor-recommended, science-based nutraceutical products.
LEHI, Utah, Oct.
Survival rates of the world's most common cancer might soon be increased with a new vitamin E treatment which could significantly reduce tumour regrowth.
SINGAPORE, Oct. 17 /PRNewswire-Asia/ -- Scientists from Singapore found that tocotrienols, which are members of the Vitamin E family, are effective in lowering the levels of triglyceride, a form of fat in the blood.
Health conscious consumers who hesitate at the price of fresh blueberries and blackberries, fruits renowned for high levels of healthful antioxidants, now have an economical alternative.
SINGAPORE, July 25 /PRNewswire-Asia/ -- Scientists from Singapore, Australia and Hong Kong have found that gamma-tocotrienol is potent in killing prostate cancer stem cells.
SINGAPORE, April 9 /PRNewswire/ -- Researchers from Davos Life Science in Singapore, in collaboration with scientists at the University of Hong Kong, have shown that gamma-tocotrienol, a member of the vitamin E family, is potent in killing prostate tumour cells in animal model studies.
- A transitional zone between two communities containing the characteristic species of each.